USPTO serial 79256290
DYNACURE
Reviewed by CopyMark Law Group
Reg. 6021035Status 709
- Filing date
- Status date
- Registration date
- Mar 31, 2020
- Examiner
- DICKSON, DANA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DYNACURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Liane L. Churney
Flynn Thiel, P.C.2026 Rambling RoadKalamazoo, MI,, 49008-1631Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the treatment of neuromuscular disorders and orphan diseases; Pharmaceutical preparations and substances for the treatment of neuromuscular disorders and orphan diseases; Biological preparations for medical use for the treatment of neuromuscular disorders and orphan diseases | SECTION 71 - CANCELLED | — |
| 042 | Scientific research; Biological and medical research services; Clinical research in the fields of neuromuscular disorders and orphan diseases; Consultancy and research and development in the field of biotechnology; Research and development services in the field of biotherapeutic products; Product development and research services for others in the field of biotechnology; Conducting clinical trials for others; Providing laboratory research services in the fields of neuromuscular disorders and orphan diseases; Medical laboratory services; Pharmaceutical research and development; Consultancy in the pharmaceutical field, namely, consulting services in the field of pharmaceutical research and development of pharmaceutical products for the treatment of neuromuscular disorders and orphan diseases; Providing information on medical and scientific research in the field of neuromuscular disorders and orphan diseases, biotechnology, pharmaceuticals, and clinical trials; Consultancy services in the field of biotechnology | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 19, 2026 | C71T | CANCELLED SECTION 71 | — |
| Mar 31, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 5, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 14, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 14, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 30, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 7, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 31, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 14, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 14, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 10, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 25, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 25, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 25, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 12, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 11, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 11, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 11, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 11, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 4, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 4, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 4, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 4, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 19, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 18, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 18, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 1, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 16, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 16, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 24, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 23, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 16, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 12, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 11, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |